COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
Neurochemical Aspects of Alzheimer's Disease - 1st Edition - ISBN: 9780128099377, 9780128099384

Neurochemical Aspects of Alzheimer's Disease

1st Edition

Risk Factors, Pathogenesis, Biomarkers, and Potential Treatment Strategies

Author: Akhlaq Farooqui
eBook ISBN: 9780128099384
Paperback ISBN: 9780128099377
Imprint: Academic Press
Published Date: 25th May 2017
Page Count: 414
Sales tax will be calculated at check-out Price includes VAT/GST
139.94
91.95
78.95
99.95
69.96
Unavailable
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Description

Neurochemical Aspects of Alzheimer's Disease provides a comprehensive overview of molecular aspects of risk factors, pathogenesis, biomarkers, and therapeutic strategies. The book focuses on molecular mechanisms and signal transduction processes associated with the pathogenesis, biomarkers, and therapeutic strategies of AD. The comprehensive and cutting edge information in this monograph may not only help in early detection of AD, but also promote discovery of new drugs to treat this chronic disease. Chapters discuss involvement of neural membrane phospholipids, sphingolipids, and cholesterol-derived lipid mediators, abnormal APP processing, and nucleic acid damage, risk factors, biomarker, and therapeutic strategies of Alzheimer's disease. This book is written for neurologists, neuroscientists, neurochemists, neuropharmacologists, and clinicianswho are interested in molecular mechanisms associated with the pathogenesis of age-related neurological disorders.

Key Features

  • Provides a comprehensive overview of molecular aspects of risk factors, pathogenesis, biomarkers, and therapeutic strategies for Alzheimer's disease
  • Written for researchers, clinicians, and advanced graduate students in neurology, neuroscience, neurochemistry, and neuropharmacology
  • Acts as the first book to provide a comprehensive description of the signal transduction processes associated with pathogenesis of Alzheimer's disease

Readership

Researchers, clinical practitioners, and advanced graduate students in clinical neuroscience, neurology, neurochemistry, and neuropharmacology

Table of Contents

1. Neurochemical Aspects of β-Amyloid Cascade Hypothesis for Alzheimer's Disease: A Critical Evaluation
2. Risk Factors for Alzheimer's Disease
3. Contribution of Neural Membrane Phospholipids (Sphingolipids) and Cholesterol in the Pathogenesis of Alzheimer's Disease
4. Contribution of Nucleic Acids in the Pathogenesis of Alzheimer's Disease
5. Type 2 Diabetes and Metabolic Syndrome as Risk Factors for Alzheimer's Disease
6. Contribution of Neuroinflammation in the Pathogenesis of Alzheimer's Disease
7. Biomarkers for Alzheimer's Disease
8. Potential Treatments for Alzheimer's Disease
9. Immunotherapy for the Treatment of Alzheimer's Disease
10. Perspective, Summary, and Directions for Future Research on Alzheimer's Disease

Details

No. of pages:
414
Language:
English
Copyright:
© Academic Press 2017
Published:
25th May 2017
Imprint:
Academic Press
eBook ISBN:
9780128099384
Paperback ISBN:
9780128099377

About the Author

Akhlaq Farooqui

Akhlaq Farooqui

Akhlaq A. Farooqui is a leader in the field of signal transduction processes, lipid mediators, phospholipases, glutamate neurotoxicity, and neurological disorders. He is a research scientist in the Department of Molecular and Cellular Biochemistry at The Ohio State University. He has published cutting edge research on the role of phospholipases A2 in signal transduction processes, generation and identification of lipid mediators during neurodegeneration by lipidomics. He has studied the involvement of glycerophospholipid, sphingolipid-, and cholesterol-derived lipid mediators in kainic acid neurotoxicity, an experimental model of neurodegenerative diseases. Akhlaq A. Farooqui has discovered the stimulation of plasmalogen- selective phospholipase A2 in brains of patients with Alzheimer disease (AD). Stimulation of this enzyme may not only be responsible for the deficiency of plasmalogens in neural membranes of AD patients, but also be related to the loss of synapse in the AD.

Affiliations and Expertise

Research Scientist, Department of Molecular and Cellular Biochemistry, The Ohio State University, Columbus, OH, USA

Ratings and Reviews